skip to content

Centre For Cancer Genetic Epidemiology

 
Read more at: CCGE researchers evaluate the contribution of gene variants to cancer risk for multiple cancer types

CCGE researchers evaluate the contribution of gene variants to cancer risk for multiple cancer types

13 March 2025

In a paper published in the American Journal of Human Genetics, CCGE researchers used data from UK Biobank to evaluate the contribution of coding variants to the heritability of 11 cancer types. The results show that gene variants make the largest contribution for ovarian cancer, followed by endometrial, pancreatic and...


Read more at: £10 million programme to use AI and state-of-the-art analytics to fight cancer

£10 million programme to use AI and state-of-the-art analytics to fight cancer

24 January 2025

Cambridge researchers are to lead a £10million project that could result in doctors being able to predict your individual chances of getting cancer and offer personalised detection and prevention. To read the full article...


Read more at: £10m funding for new programme to help identify individual cancer risk

£10m funding for new programme to help identify individual cancer risk

24 January 2025

Early detection of cancer is key to saving lives, because cancer diagnosed at an early stage, when it isn’t too large and hasn’t spread, is more likely to be treated successfully. But according to our analysis of NHS figures, currently only 54.4% of cancers are diagnosed at stages one and two*. But that could all be about...